Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04VYE
|
|||
| Drug Name |
Benzyl pyrrolyloxoacetamide derivative 2
|
|||
| Synonyms |
PMID26413912-Compound-90
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
IRONWOOD PHARMACEUTICALS, INCIRONWOOD PHARMACEUTICALS, INC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H19F3N4O4
|
|||
| Canonical SMILES |
CC1=C(C2=CC(=C(C=C2N1CC3=C(C=C(C=N3)F)F)F)OC)C(=O)C(=O)NC4=CC(=NC=C4)OC
|
|||
| InChI |
1S/C24H19F3N4O4/c1-12-22(23(32)24(33)30-14-4-5-28-21(7-14)35-3)15-8-20(34-2)17(27)9-19(15)31(12)11-18-16(26)6-13(25)10-29-18/h4-10H,11H2,1-3H3,(H,28,30,33)
|
|||
| InChIKey |
SUOOBQNAIURDKV-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fatty acid amide hydrolase (FAAH) | Target's Patent Info | [1] | |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.